(19)
(11) EP 3 049 440 A1

(12)

(43) Date of publication:
03.08.2016 Bulletin 2016/31

(21) Application number: 14782039.3

(22) Date of filing: 25.09.2014
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C07K 16/32(2006.01)
(86) International application number:
PCT/US2014/057432
(87) International publication number:
WO 2015/048272 (02.04.2015 Gazette 2015/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 25.09.2013 US 201361882428 P

(71) Applicant: Amgen Inc.
Thousand Oaks, California 91320-1799 (US)

(72) Inventors:
  • MICHAELS, Mark, L.
    Encino, CA 91316 (US)
  • BORGES, Luis, G.
    San Mateo, CA 94044 (US)
  • YAN, Wei
    Sammamish, WA 98075 (US)

(74) Representative: Schiweck, Weinzierl & Koch 
European Patent Attorneys Landsberger Straße 98
80339 München
80339 München (DE)

   


(54) V-C-FC-V-C ANTIBODY